19 results
8-K
EX-99.1
VIR
Vir Biotechnology Inc
28 Jun 21
Other Events
6:07am
response through Week 48 In combination studies, VIR is exploring 3-6 doses of VIR-2218 Diversity of response being explored through immune biomarkers
DEF 14A
i5q0q
6 Apr 20
Definitive proxy
4:52pm
DRS
q9q1qhpp2lx9n6
27 Jun 19
Draft registration statement
12:00am
10-K
9bhh6ju6dam
26 Mar 20
Annual report
4:08pm
DRS/A
9hwypas6c l98
7 Aug 19
Draft registration statement (amended)
12:00am
424B4
kjia85dvaizyoil47dhy
11 Oct 19
Prospectus supplement with pricing info
5:31pm
S-1
x7covsp2p
3 Sep 19
IPO registration
4:40pm
S-1/A
bdqcb7ro
30 Sep 19
IPO registration (amended)
6:12am
- Prev
- 1
- Next